Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much funding his Department has provided for the provision of home dialysis to each NHS trust in England in the last 12 months.
Answered by Will Quince
This information requested on funding in 2022 is not currently held centrally. However, in 2021/22, NHS England provided approximately £117 million to renal providers in England for the provision of home dialysis therapy. This is inclusive of haemodialysis and all modalities of peritoneal dialysis. The following table shows funding provided by NHS England to each specialist renal provider in England in 2021/22.
Aintree University Hospital NHS Foundation Trust £996,247
Barts Health NHS Trust £9,873,038
Bradford Teaching Hospitals NHS Foundation Trust £841,162
Cambridge University Hospitals NHS Foundation Trust £1,297,309
Doncaster and Bassetlaw Teaching Hospitals NHS Foundation
Trust £510,650
Dorset County Hospital NHS Foundation Trust £933,545
East and North Hertfordshire NHS Trust £1,832,292
East Kent Hospitals University NHS Foundation Trust £2,210,524
East Suffolk and North Essex NHS Foundation Trust £919,822
Epsom and St Helier University Hospitals NHS Trust £3,800,712
Gloucestershire Hospitals NHS Foundation Trust £135,252
Guy's and St Thomas' NHS Foundation Trust £3,191,945
Hull University Teaching Hospitals NHS Trust £1,344,022
Imperial College Healthcare NHS Trust £6,704,239
King's College Hospital NHS Foundation Trust £5,583,181
Lancashire Teaching Hospitals NHS Foundation Trust £2,356,531
Leeds Teaching Hospitals NHS Trust £1,806,242
Liverpool University Hospitals NHS Foundation Trust £1,772,510
Manchester University NHS Foundation Trust £4,634,713
Mid and South Essex NHS Foundation Trust £2,668,753
Norfolk and Norwich University Hospitals NHS Foundation
Trust £1,430,263
North Bristol NHS Trust £2,128,904
North Cumbria Integrated Care NHS Foundation Trust £731,871
Nottingham University Hospitals NHS Trust £3,111,524
Oxford University Hospitals NHS Foundation Trust £2,169,549
Portsmouth Hospitals NHS Trust £4,819,664
Royal Berkshire NHS Foundation Trust £1,483,022
Royal Devon and Exeter NHS Foundation Trust £2,091,381
Royal Free London NHS Foundation Trust £5,252,797
Salford Royal NHS Foundation Trust £2,718,068
Sheffield Teaching Hospitals NHS Foundation Trust £3,413,902
Shrewsbury and Telford Hospital NHS Trust £2,027,726
South Tees Hospitals NHS Foundation Trust £857,527
South Tyneside and Sunderland NHS Foundation Trust £1,294,611
St George's University Hospitals NHS Foundation Trust £1,699,134
The Dudley Group NHS Foundation Trust £976,574
The Newcastle Upon Tyne Hospitals NHS Foundation Trust £1,843,691
The Royal Wolverhampton NHS Trust £2,340,870
University Hospitals Birmingham NHS Foundation Trust £5,578,386
University Hospitals Coventry and Warwickshire NHS Trust £2,410,502
University Hospitals of Derby and Burton NHS Foundation
Trust £3,127,492
University Hospitals of Leicester NHS Trust £4,318,784
University Hospitals of North Midlands NHS Trust £3,006,318
University Hospitals Plymouth NHS Trust £836,807
University Hospitals Sussex NHS Foundation Trust £2,199,773
York Teaching Hospital NHS Foundation Trust £1,056,816
Wirral University Teaching Hospital NHS Foundation Trust £267,484
Total £116,606,127
The information requested on funding passed to patients is not held centrally as renal providers have local arrangements in place with patients to facilitate reimbursement.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to raise awareness amongst clinicians that brain fog can be a symptom of both dementia and menopause.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
A Women’s Health Ambassador for England has been appointed to raise the profile for women’s heath, including the menopause and long term conditions, such as dementia. The Ambassador will support implementation of the Women’s Health Strategy, in which the menopause is a priority area.
NHS England is supporting clinicians to deliver improved menopause care through a clinical pathway being developed by a menopause clinical reference group, which will include the symptoms of concentration-loss or ‘brain fog’.
The NHS Health Check for adults in England aged 45 to 74 years old is designed to identify early signs of stroke, kidney disease, heart disease, type 2 diabetes or dementia. Since 2018, dementia risk reduction has been incorporated within the NHS Health Check to increase awareness and motivate people to reduce their risks. In addition, those aged 65 years old and over are made aware of the signs and symptoms of dementia and guided to memory clinics.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the number of women referred to Memory Services when experiencing cognitive symptoms of menopause.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
No specific assessment has been made as data on the number of menopausal women referred to memory services is not held centrally.
However, NHS England has undertaken preliminary work to deliver improved menopause care. An optimal clinical pathway is currently being developed by a menopause clinical reference group, which will include memory-loss and concentration-loss as symptoms women may present with.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to provide additional support for research into potential links between dementia and the menopause.
Answered by James Morris
The National Institute for Health and Care Research (NIHR) welcomes funding applications for research into any aspect of human health, including into dementia and the menopause. The NIHR’s School for Primary Care Research has funded an observational study investigating the risks of developing dementia associated with menopausal hormone therapies.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many women received Hormone Replacement Therapy prescriptions for (a) utrogestan, (b) body-identical oestrogen patches and gels, (c) non-body-identical oestrogen, (d) non-body identical progestogens and (d) the testosterone products (i) testogel, (ii) testim and (iii) tostran in each of the last ten years by Parliamentary constituency or the lowest available administrative level if that data is not available.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The information is not held in the format requested.
The attached table shows items dispensed in the community at clinical commissioning group level in England from 2015/16 to 2021/22.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether it is his policy that there should be a comprehensive public health framework for gambling policy in the UK.
Answered by Maggie Throup
The Department for Digital, Culture, Media and Sport is the lead department responsible for gambling policy. We continue to work with the Department for Digital, Culture Media and Sport on the current public health approach to addressing harmful gambling.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of clinicians' recommendation that there should be a levy board responsible for a statutory gambling levy in the UK.
Answered by Maggie Throup
We are working with the Department for Digital, Culture, Media and Sport to assess the effectiveness of existing funding arrangements to support projects and services related to problem gambling. This includes the appropriate governance structures to oversee this funding. The Department for Digital, Culture, Media and Sport’s white paper with proposals for reform is expected to be published shortly.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans his Department has for a public health campaign to update women on the menopause support available to them.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The UK Menopause Taskforce’s first meeting, held on 3 February 2022, agreed that future meetings would be scheduled by themes, including education and awareness. This will consider how to ensure that women, the general public and healthcare professionals are well-informed about the menopause. In December 2021, the Department announced plans to appoint the first Women’s Health Ambassador for England. The Ambassador will focus on raising the profile for women’s health issues, such as the menopause, increasing awareness of taboo topics and including a range of collaborative voices to implement the Women’s Health Strategy.
The forthcoming Women’s Health Strategy will also contain a priority menopause chapter detailing the support available to menopausal individuals.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health and Social Care on 29 October 2021, Official Report, column 538, what progress he has made on reducing the costs of repeatable prescriptions for HRT for women experiencing menopausal symptoms.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Subject to consultation with relevant professional bodies, we will deliver the cost reduction through a bespoke pre-payment certificate (PPC) for hormone replacement therapy. As a PPC usually applies to all medicines on National Health Service prescriptions, we are working with the NHS Business Services Authority to implement a solution as soon as possible.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans his Department has write to healthcare professionals to remind them of the NICE guidelines for menopause care and the ability to prescribe twelve months supply on one prescription; and what his timetable is for doing that.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department is in discussions with the Royal College of General Practitioners and other stakeholders on communications to healthcare professionals on the National Institute for Health and Care Excellence’s (NICE) guidelines for menopause care.
NICE’s guideline recommends that each treatment for short-term menopausal symptoms should be reviewed at three months to assess efficacy and tolerability and annually thereafter, unless there are clinical indications for an earlier review. NICE does not make recommendations on length of prescription as this is a clinical decision. However, NHS England and NHS Improvement advise that general practitioners can prescribe up to 12 month’s supply, where clinically appropriate.